000 01627 a2200445 4500
005 20250515014031.0
264 0 _c20060727
008 200607s 0 0 eng d
022 _a1046-6673
024 7 _a10.1681/ASN.2005050571
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShibata, Shigeru
245 0 0 _aFluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
_h[electronic resource]
260 _bJournal of the American Society of Nephrology : JASN
_cMar 2006
300 _a754-64 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute-Phase Proteins
_xdrug effects
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aBlotting, Western
650 0 4 _aDisease Models, Animal
650 0 4 _aFatty Acids, Monounsaturated
_xpharmacology
650 0 4 _aFluvastatin
650 0 4 _aImmunohistochemistry
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aMale
650 0 4 _aPodocytes
_xdrug effects
650 0 4 _aProbability
650 0 4 _aProteinuria
_xpathology
650 0 4 _aPuromycin Aminonucleoside
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSensitivity and Specificity
650 0 4 _aSignal Transduction
700 1 _aNagase, Miki
700 1 _aFujita, Toshiro
773 0 _tJournal of the American Society of Nephrology : JASN
_gvol. 17
_gno. 3
_gp. 754-64
856 4 0 _uhttps://doi.org/10.1681/ASN.2005050571
_zAvailable from publisher's website
999 _c16066066
_d16066066